Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Works by El-Naggar, Sabry Ali
Results: 13
1
2
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02284-3
- By:
- Publication type:
- Article
3
Co-Treatment with Cranberry and Vitamin-C Mitigates Reproductive Toxicities Induced by Phenobarbital in Male Rats.
- Published in:
- Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2024, v. 58, n. 6, p. 722, doi. 10.33594/000000745
- By:
- Publication type:
- Article
4
Toxicity of bean cooking media containing EDTA in mice.
- Published in:
- Toxicology & Industrial Health, 2020, v. 36, n. 6, p. 436, doi. 10.1177/0748233719893178
- By:
- Publication type:
- Article
5
The Rationale of Gingerol as a Main Phenolic Compound of Zingiber in Improving Hepatocellular Carcinoma Induced by Dimethylaminoazobenzene: Scientific Implication.
- Published in:
- Egyptian Academic Journal of Biological Sciences. D, Histology & Histochemistry, 2022, v. 14, n. 2, p. 25, doi. 10.21608/EAJBSD.2022.254286
- By:
- Publication type:
- Article
6
The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications.
- Published in:
- Egyptian Academic Journal of Biological Sciences. D, Histology & Histochemistry, 2022, v. 14, n. 2, p. 13, doi. 10.21608/EAJBSD.2022.253527
- By:
- Publication type:
- Article
7
The Rationale of Diarylheptanoid in Ameliorating DimethylaminoazobenzeneInduced Hepatocellular Carcinoma: Methodical Implication.
- Published in:
- Egyptian Academic Journal of Biological Sciences. D, Histology & Histochemistry, 2022, v. 14, n. 1, p. 171, doi. 10.21608/EAJBSD.2022.242354
- By:
- Publication type:
- Article
8
Biochemical Characterisation and in vitro Antitumour Effect of Parotoid Gland Secretions of the Egyptian Toad (Bufo relgularis).
- Published in:
- Tropical Life Sciences Research, 2024, v. 35, n. 2, p. 65, doi. 10.21315/tlsr2024.35.2.4
- By:
- Publication type:
- Article
9
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, v. 396, n. 11, p. 3087, doi. 10.1007/s00210-023-02511-8
- By:
- Publication type:
- Article
10
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, v. 396, n. 10, p. 2501, doi. 10.1007/s00210-023-02470-0
- By:
- Publication type:
- Article
11
Treatment with Nigella sativa oil ameliorated the hepato-renal toxicities induced by cyclophosphamide in splenectomized mice.
- Published in:
- Egyptian Journal of Experimental Biology (Zoology), 2017, v. 13, n. 2, p. 291, doi. 10.5455/egysebz.20171105115054
- By:
- Publication type:
- Article
12
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10517-0
- By:
- Publication type:
- Article
13
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10517-0
- By:
- Publication type:
- Article